Arul Chinnaiyan
Corporate Officer/Principal at University of Michigan
Profile
Arul Chinnaiyan is the founder of Oncofusion Therapeutics, Inc. which was founded in 2012.
Currently, he is a Professor at the University of Michigan and an Advisor at Brightedge Ventures.
Previously, he worked as the President & Director at Lynx Dx, Inc.
Arul Chinnaiyan active positions
| Companies | Position | Start |
|---|---|---|
| University of Michigan | Corporate Officer/Principal | 2010-03-10 |
Brightedge Ventures
 Brightedge Ventures Investment ManagersFinance Brightedge Ventures (Brightedge Ventures) is a venture capital subsidiary of American Cancer Society, Inc founded in 2018. The firm is headquartered in Atlanta, Georgia. | Consultant / Advisor | - |
Former positions of Arul Chinnaiyan
| Companies | Position | End |
|---|---|---|
Lynx Dx, Inc.
 Lynx Dx, Inc. Medical SpecialtiesHealth Technology Lynx Dx, Inc. provides health care services. It focuses on commercializing diagnostic tools. The company is headquartered in Ann Arbor, MI. | President | - |
Oncofusion Therapeutics, Inc.
 Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Health Technology |
Brightedge Ventures
Brightedge Ventures Investment ManagersFinance Brightedge Ventures (Brightedge Ventures) is a venture capital subsidiary of American Cancer Society, Inc founded in 2018. The firm is headquartered in Atlanta, Georgia. | Finance |
Lynx Dx, Inc.
Lynx Dx, Inc. Medical SpecialtiesHealth Technology Lynx Dx, Inc. provides health care services. It focuses on commercializing diagnostic tools. The company is headquartered in Ann Arbor, MI. | Health Technology |
- Stock Market
- Insiders
- Arul Chinnaiyan
